- Home
- ATIF vs NTBL Comparison
ATIF vs NTBL Comparison
Compare ATIF & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATIF
- NTBL
- Stock Information
- Founded
- ATIF 2015
- NTBL 2000
- Country
- ATIF United States
- NTBL United States
- Employees
- ATIF N/A
- NTBL N/A
- Industry
- ATIF Professional Services
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- ATIF Consumer Discretionary
- NTBL Health Care
- Exchange
- ATIF Nasdaq
- NTBL Nasdaq
- Market Cap
- ATIF 9.8M
- NTBL 4.6M
- IPO Year
- ATIF 2019
- NTBL N/A
- Fundamental
- Price
- ATIF $0.86
- NTBL $0.34
- Analyst Decision
- ATIF
- NTBL Buy
- Analyst Count
- ATIF 0
- NTBL 2
- Target Price
- ATIF N/A
- NTBL $5.00
- AVG Volume (30 Days)
- ATIF 214.7K
- NTBL 8.0M
- Earning Date
- ATIF 12-13-2024
- NTBL 11-12-2024
- Dividend Yield
- ATIF N/A
- NTBL N/A
- EPS Growth
- ATIF N/A
- NTBL N/A
- EPS
- ATIF N/A
- NTBL N/A
- Revenue
- ATIF $500,000.00
- NTBL $313,000.00
- Revenue This Year
- ATIF N/A
- NTBL N/A
- Revenue Next Year
- ATIF N/A
- NTBL N/A
- P/E Ratio
- ATIF N/A
- NTBL N/A
- Revenue Growth
- ATIF N/A
- NTBL 3812.50
- 52 Week Low
- ATIF $0.58
- NTBL $0.22
- 52 Week High
- ATIF $1.50
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- ATIF 46.75
- NTBL 43.04
- Support Level
- ATIF $0.85
- NTBL $0.28
- Resistance Level
- ATIF $1.50
- NTBL $0.67
- Average True Range (ATR)
- ATIF 0.18
- NTBL 0.06
- MACD
- ATIF -0.01
- NTBL -0.00
- Stochastic Oscillator
- ATIF 15.82
- NTBL 27.53
About ATIF ATIF Holdings Limited
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.